How fusion proteins drive paediatric cancer
Researchers discover that fusion proteins and a gene regulatory protein complex interact through disordered domains.
List view / Grid view
Researchers discover that fusion proteins and a gene regulatory protein complex interact through disordered domains.
Tune in to this episode where we discuss the opportunities CRISPR/Cas technology offers to revolutionise drug discovery.
Proteins regulating plasminogen-plasmin levels can be used to identify patients at risk of progressing to a severe stage of COVID-19.
Researchers have developed an algorithm which could improve diagnostics of ovarian high-grade serous carcinoma.
Researchers find that the RAD51 protein prevents genomic duplications that could arise from reactivated origins.
The potential for brain organoids to develop consciousness is a key issue in neuroscience, which has prompted new ethical considerations.
The study's findings could be applied to the development of new vaccine and therapeutic strategies for influenza.
Researchers find that an overgrowth of nerve cells in the bladder could cause rUTIs, which may offer new approaches to manage symptoms.
Treatment with Palbociclib and a compound targeting CAD increased survival to 100 percent for selected lymphoma cell lines.
Researchers have generated a SASP atlas of human colon fibroblasts and assessed the resulting transcriptome.
Researchers have developed a system that enabled quantitative assessment of cytotoxicity of SiNPs in human hepatoma cells.
Limb bud progenitor cells efficiently generated new cartilage in osteoarthritis patients, which could lead to cartilage replacement therapy.
A highly specific blood test can differentiate between patients with sarcoidosis and other respiratory conditions, like TB or lung cancer.
Listen to this podcast where we we explore the latest technological advancements in high throughput screening and more.
Researchers have discovered that higher expression of gigaxonin suppresses aggressive growth of human head and neck cancer cells.